Innovation-driven Strategies

At Fochon, we seamlessly integrate the art of traditional medicinal chemistry with the modern technology of structure-based drug design. This integration culminates in our proprietary compound generation, optimization and preclinical/clinical development. Our expertise and experience allow us to proficiently and rapidly create a risk-diversified portfolio of  drug candidate pipelines by:

  • Focusing primarily on clinically validated targets & druggable chemical scaffolds with known pharmacophores.
  • Tapping into the talents and resources in both China and US, creating a highly efficient, expedited and cost effective global operating structure.
  • Independently or cooperatively advancing the development from pre-clinical to clinical stages to balance development risk and expenditure.